ONCOLOGIE, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 7, 2024
Language: Английский
ONCOLOGIE, Journal Year: 2024, Volume and Issue: unknown
Published: Oct. 7, 2024
Language: Английский
Food Bioscience, Journal Year: 2024, Volume and Issue: 62, P. 105088 - 105088
Published: Sept. 10, 2024
Language: Английский
Citations
10Cellular Signalling, Journal Year: 2025, Volume and Issue: 127, P. 111606 - 111606
Published: Jan. 13, 2025
Clear cell renal carcinoma (ccRCC) is a common clinical tumor of the urinary system. The lack effective diagnostic and treatment options poses serious challenge to treatment. Therefore, identifying molecular targets has become one potential means treat this disease. Firstly, analysis TCGA database found that PLAC1 was abnormally highly expressed in ccRCC negatively correlated with patient prognosis. Western blotting immunofluorescence experiments further verified patients, knockdown inhibited development vitro. Last, high-throughput virtual screening technology (HTVS) performed identify two inhibitors ,AmB Cana, which were able reduce expression progression ccRCC. In conclusion, current investigation indicated could serve as prognostic biomarker, AmB Cana inhibit by reducing PLAC1, making it therapeutic option for
Language: Английский
Citations
1Molecular Diversity, Journal Year: 2024, Volume and Issue: unknown
Published: Sept. 3, 2024
Abstract NUDIX hydrolase 5 (NUDT5) is an enzyme involved in the hydrolysis of nucleoside diphosphates linked to other moieties, such as ADP-ribose. This cofactor vital redox reactions and essential for activity sirtuins poly(ADP-ribose) polymerases, which are DNA repair genomic stability. It has been shown that NUDT5 can also influence NAD+ homeostasis, thereby affecting cancer cell metabolism survival. In this regard, discovery inhibitors emerged a potential therapeutic approach treatment. study, we conducted high-throughput virtual screening marine bacterial compounds against four molecules were selected based on their docking scores. These established strong interactions within active site, with molecular analysis highlighting key role Trp 28A 46B residues. Molecular dynamics simulations over 200 ns indicated stable behavior, association root mean square deviation values always below 3 Å, suggesting conformational Free energy landscape further supported inhibitors, offering avenues novel strategies NUDT5-associated breast cancer.
Language: Английский
Citations
4Naunyn-Schmiedeberg s Archives of Pharmacology, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 11, 2025
Language: Английский
Citations
0Bioorganic & Medicinal Chemistry Letters, Journal Year: 2025, Volume and Issue: unknown, P. 130133 - 130133
Published: Feb. 1, 2025
Language: Английский
Citations
0Bioorganic Chemistry, Journal Year: 2025, Volume and Issue: 160, P. 108482 - 108482
Published: April 16, 2025
Language: Английский
Citations
0Sci, Journal Year: 2025, Volume and Issue: 7(1), P. 2 - 2
Published: Jan. 2, 2025
The conversion of betulinic acid (BA) to organic salts is a strategic approach modulate its physicochemical properties and biological activity. In our previous study, we demonstrated the enhanced cytotoxicity certain amino ethyl ester betulinates ([AAOEt][BA]) compared BA against hormone-dependent breast cancer cells (MCF-7). this extended investigation evaluate cytotoxic response thermodynamic hormone-independent (MDA-MB-231) following 72 h treatment with same series betulinates. Our data reveal lower in MDA-MB-231 cells, indicated by higher half-maximal inhibitory concentration (IC50) values, which ranged between 31 109 μM. Differential scanning calorimetry analysis supported these findings, showing negligible changes parameters treated cells. However, consistent observations, [LysOEt][BA]2, exhibited highest induced most pronounced morphological alterations Overall, results suggest that are less sensitive [AAOEt][BA] MCF-7 likely due their distinct phenotypic genotypic profiles differences oncogenic signalling pathways. Nonetheless, fact [LysOEt][BA]2 enhances activity even underscores therapeutic potential warrants further investigation, particularly context adjuvant therapy.
Language: Английский
Citations
0Molecular Diversity, Journal Year: 2025, Volume and Issue: unknown
Published: Jan. 23, 2025
Language: Английский
Citations
0Chemico-Biological Interactions, Journal Year: 2025, Volume and Issue: 409, P. 111422 - 111422
Published: Feb. 15, 2025
Language: Английский
Citations
0European Journal of Medicinal Chemistry, Journal Year: 2025, Volume and Issue: 288, P. 117412 - 117412
Published: Feb. 18, 2025
Language: Английский
Citations
0